Fibrinogen binds to growth factors, such as fibroblast growth factor-2 (FGF-2, bFGF) and (VEGF, to enhance tumor growth and increase the migration, invasion, and metastasis of tumor cells, as well as angiogenesis—processes which are considered to be hallmarks of cancer. This evidence concerns the gene FGF2 and cancer.